Heron Therapeuti Stock Analysis

Heron Stock Analysis Notes

About 82.0% of the company shares are owned by institutional investors. The company recorded a loss per share of 0.16. Heron Therapeuti had not issued any dividends in recent years. The entity had 1:20 split on the 13th of January 2014. Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs. Heron Therapeutics, Inc. was founded in 1983 and is headquartered in San Diego, California. Heron Therapeutics operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 302 people. To learn more about Heron Therapeuti call Barry PharmD at 858 251 4400 or check out https://www.herontx.com.

Heron Therapeuti Investment Alerts

Heron Therapeuti Upcoming and Recent Events

Heron Largest EPS Surprises

View All Earnings Estimates

Heron Therapeuti Thematic Classifications

Heron Stock Institutional Investors

Note, although Heron Therapeuti's institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Heron Market Capitalization

The company currently falls under 'Small-Cap' category with a current market capitalization of 170.35 M.

Heron Profitablity

The company has Profit Margin (PM) of (0.2) %, which may suggest that it does not properly executes on its current pricing strategies or is unable to control all of the operational costs. This is way below average. Similarly, it shows Operating Margin (OM) of (0.14) %, which suggests for every $100 dollars of sales, it generated a net operating loss of $0.14.

Management Efficiency

Heron Therapeuti has return on total asset (ROA) of (0.0231) % which means that it has lost $0.0231 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (24.0888) %, meaning that it created substantial loss on money invested by shareholders. Heron Therapeuti's management efficiency ratios could be used to measure how well Heron Therapeuti manages its routine affairs as well as how well it operates its assets and liabilities. Return On Equity is likely to rise to 3.42 in 2024, whereas Return On Tangible Assets are likely to drop (0.52) in 2024. At this time, Heron Therapeuti's Total Assets are fairly stable compared to the past year. Non Current Assets Total is likely to rise to about 35.4 M in 2024, whereas Other Current Assets are likely to drop slightly above 5.5 M in 2024.

Technical Drivers

As of the 22nd of November, Heron Therapeuti retains the Market Risk Adjusted Performance of (0.28), standard deviation of 5.02, and Risk Adjusted Performance of (0.09). Heron Therapeuti technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.

Heron Therapeuti Price Movement Analysis

Heron Therapeuti Insider Trading Activities

Heron Therapeuti Outstanding Bonds

Heron Therapeuti Predictive Daily Indicators

Heron Therapeuti Forecast Models

Heron Therapeuti's time-series forecasting models are one of many Heron Therapeuti's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Heron Therapeuti's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Heron Therapeuti prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Heron shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Heron Therapeuti. By using and applying Heron Stock analysis, traders can create a robust methodology for identifying Heron entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Heron analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Heron analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Heron Therapeuti stock analysis indicators help investors evaluate how Heron Therapeuti stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Heron Therapeuti shares will generate the highest return on investment. By understating and applying Heron Therapeuti stock analysis, traders can identify Heron Therapeuti position entry and exit signals to maximize returns.

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.